1383729-63-2

Upstream product

• 1315495-07-8 4-(5-amino-1-benzenesulphonyl-1H-pyrrolo[2,3-b]pyridine-4ylamino)piperidine-1-carboxylic acid tert-butyl ester 
• 1315495-05-6 4-(1-benzenesulphonyl-5-nitro-1H-pyrrolo[2,3-b]pyridine-4ylamino)piperidine-1-carboxylic acid tert-butyl ester 
• 1383729-62-1 4-(3-benzenesulfonyl-7-dimethylamino-8-oxo-3,8-dihydro-3,4,6,9-tetraazacyclopenta[a]naphthalen-9-yl)piperidine-1-carboxylic acid tert-butyl ester 
• 1383729-61-0 4-(3-benzenesulfonyl-7-chloro-8-oxo-3,8-dihydro-3,4,6,9-tetraazacyclopenta[a]naphthalen-9-yl)piperidine-1-carboxylic acid tert-butyl ester 
• 1245649-52-8 1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine 
• 1383729-54-1 4-(3-benzenesulfonyl-7,8-dioxo-3,6,7,8-tetrahydro-3,4,6,9-tetraazacyclopenta[a]naphthalen-9-yl)piperidine-1-carboxylic acid tert-butyl ester 
• 744209-63-0 1-(benzenesulfonyl)-4-chloro-1H-pyrrolo[2,3-b]pyridine 
• 55052-28-3 4-chloro-7-azaindole 
• 98-09-9 benzenesulfonyl chloride 

Downstream Products

• 1383729-64-3 3-[4-(3-benzenesulfonyl-7-dimethylamino-8-oxo-3,8-dihydro-3,4,6,9-tetraazacyclopenta[a]naphthalen-9-yl)piperidin-1-yl]propionitrile 

Relevant academic research and scientific papers

TRICYCLIC PYRAZINONE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF AS JANUS KINASE INHIBITORS

The invention provides novel compounds of formula I having the general formula (I) wherein X, R1, R2, R3 and R5 are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.